Jacobson, Jennie G.
Eli Lilly (United States)
4 papers on CoChatORCID 0000-0002-7489-7784
Most cited papers
- Verified
Pharmacokinetics and pharmacodynamics of high-dose human regular U-500 insulin versus human regular U-100 insulin in healthy obese subjects
de la Peña, A., Riddle, M., Morrow, L. A., Jiang, H. H., Linnebjerg, H., Scott, A., Win, K. M., Hompesch, M., Mace, K. F., Jacobson, J. G., et al. (2011) · Diabetes Care
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 125
- Verified
Olanzapine Plasma Concentrations After Treatment With 10, 20, and 40 mg/d in Patients With Schizophrenia: An Analysis of Correlations With Efficacy, Weight Gain, and Prolactin Concentration
Citrome, L., Stauffer, V. L., Chen, L., Kinon, B. J., Kurtz, D. L., Jacobson, J. G., & Bergstrom, R. F. (2009) · Journal of Clinical Psychopharmacology
Schizophrenia research and treatmentPharmacogenetics and Drug Metabolism
Cited by 88
- Verified
Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment
Judge, R., Parry, M. G., Quail, D., & Jacobson, J. G. (2002) · International Clinical Psychopharmacology
Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Cited by 87
- Verified
Fluoxetine 40–60 mg versus Fluoxetine 20 mg in the Treatment of Children and Adolescents with a Less-Than-Complete Response to Nine-Week Treatment with Fluoxetine 10–20 mg: APilot Study
Heiligenstein, J. H., Hoog, S. L., Wagner, K. D., Findling, R. L., Galil, N., Kaplan, S., Busner, J., Nilsson, M. E., Brown, E. B., & Jacobson, J. G. (2006) · Journal of Child and Adolescent Psychopharmacology
Treatment of Major DepressionChild and Adolescent Psychosocial and Emotional Development
Cited by 39
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free